BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Irani SR, Gelfand JM, Al-Diwani A, Vincent A. Cell-surface central nervous system autoantibodies: clinical relevance and emerging paradigms. Ann Neurol 2014;76:168-84. [PMID: 24930434 DOI: 10.1002/ana.24200] [Cited by in Crossref: 131] [Cited by in F6Publishing: 139] [Article Influence: 14.6] [Reference Citation Analysis]
Number Citing Articles
1 Qin X, Li J, Luo Y, He Y, Xiao X, Tan A, Xiao J. Anti-contactin-associated protein-like 2 antibody autoimmune encephalitis with rapidly progressive parkinsonism: a case report and literature review. Acta Neurol Belg. [DOI: 10.1007/s13760-022-02124-7] [Reference Citation Analysis]
2 Lenti MV, Rossi CM, Melazzini F, Gastaldi M, Bugatti S, Rotondi M, Bianchi PI, Gentile A, Chiovato L, Montecucco C, Corazza GR, Di Sabatino A. Seronegative autoimmune diseases: A challenging diagnosis. Autoimmun Rev 2022;21:103143. [PMID: 35840037 DOI: 10.1016/j.autrev.2022.103143] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
3 Algahtani H, Shirah B, Attar A, Alghaythee H. Contactin-associated protein-like 2 (CASPR2) autoantibody-related pancerebellar syndrome. Acta Neurol Belg 2022;122:805-8. [PMID: 33772452 DOI: 10.1007/s13760-021-01658-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Lee ST, Lee HS, Lee WJ, Cha HA, Kim SH, Shin SY, Chu K, Lee SK. The safety and efficacy of intravenous immunoglobulin in autoimmune encephalitis. Ann Clin Transl Neurol 2022. [PMID: 35315247 DOI: 10.1002/acn3.51540] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Warken M, Hambsch N, Tews B, Martins dos Santos M, Niggemann P, Wolf J. Anti-NMDA(N-Methyl-D-Aspartat)-Rezeptor-Enzephalitis bei kleinzelligem Bronchialkarzinom mit schwerer autonomer Beteiligung in Form einer Hypothermie. DGNeurologie 2022;5:136-139. [DOI: 10.1007/s42451-022-00412-3] [Reference Citation Analysis]
6 Liu C, Ji S, Gao H, Bi Z, Zhang Q, Shang K, Cao J, Bu B. Efficacy of tacrolimus as long-term immunotherapy for neuronal surface antibody-mediated autoimmune encephalitis. Ther Adv Chronic Dis 2022;13:20406223211063055. [PMID: 35035868 DOI: 10.1177/20406223211063055] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Hébert J, Muccilli A, Wennberg RA, Tang-Wai DF. Autoimmune Encephalitis and Autoantibodies: A Review of Clinical Implications. J Appl Lab Med 2022;7:81-98. [PMID: 34996085 DOI: 10.1093/jalm/jfab102] [Reference Citation Analysis]
8 Nonaka T, Ebisu I, Ohashi I, Shizukawa H, Shimohama S. Morvan syndrome associated with unresectable thymoma responsive to chemotherapy: a case report. Rinsho Shinkeigaku 2022;62:615-620. [DOI: 10.5692/clinicalneurol.cn-001729] [Reference Citation Analysis]
9 Cai M, Zheng Y, Wang S, Lai Q, Fang G, Shen C, Xu Y, Zhang Y, Ding M. Clinical Relevance of Cerebrospinal Fluid Antibody Titers in Anti-N-Methyl-d-Aspartate Receptor Encephalitis. Brain Sciences 2021;12:4. [DOI: 10.3390/brainsci12010004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
10 Chen W, Wang M, Gao L, Huang Z, Lin Y, Xue Q, Liu G, Zhang Y, Su Y. Neurofunctional outcomes in patients with anti-leucine-rich glioma inactivated 1 encephalitis. Acta Neurol Scand 2021;144:632-9. [PMID: 34314015 DOI: 10.1111/ane.13503] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
11 Smyth D, Kyaw KM, Legister A, MacFarlane G, Sankar UU, Patel M, Clough C, Kulendran A, Mulroy E. Post-COVID-19 opsoclonus-myoclonus syndrome and encephalopathy associated with leucine-rich glioma-inactivated 1 (LGI-1) antibodies. J Neurol Sci 2021;430:119982. [PMID: 34543933 DOI: 10.1016/j.jns.2021.119982] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
12 Akhtershaheenk33@gmail.com S. Epilepsy: A Common Co-Morbidity in ASD. Autism Spectrum Disorder - Profile, Heterogeneity, Neurobiology and Intervention 2021. [DOI: 10.5772/intechopen.96484] [Reference Citation Analysis]
13 Wagner-altendorf TA, Cirkel A, Münte TF. Limbic encephalitis due to antineuronal antibodies. Zeitschrift für Neuropsychologie 2021;32:24-29. [DOI: 10.1024/1016-264x/a000315] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
14 Ali F, Wijdicks EF. Treatment of Movement Disorder Emergencies in Autoimmune Encephalitis in the Neurosciences ICU. Neurocrit Care 2020;32:286-94. [PMID: 31732848 DOI: 10.1007/s12028-019-00875-5] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 3.5] [Reference Citation Analysis]
15 Besag FMC, Vasey MJ. Seizures and Epilepsy in Autism Spectrum Disorder. Psychiatr Clin North Am 2021;44:51-68. [PMID: 33526237 DOI: 10.1016/j.psc.2020.11.005] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
16 Lee ST, Lee BJ, Bae JY, Kim YS, Han DH, Shin HS, Kim S, Park DK, Seo SW, Chu K, Lee SK, Ho WK. CaV α2δ Autoimmune Encephalitis: A Novel Antibody and its Characteristics. Ann Neurol 2021;89:740-52. [PMID: 33415786 DOI: 10.1002/ana.26017] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
17 Irani SR. Paraneoplastic and Nonparaneoplastic Autoimmune Syndromes of the Nervous System. Aminoff's Neurology and General Medicine 2021. [DOI: 10.1016/b978-0-12-819306-8.00027-7] [Reference Citation Analysis]
18 Kao YC, Lin MI, Weng WC, Lee WT. Neuropsychiatric Disorders Due to Limbic Encephalitis: Immunologic Aspect. Int J Mol Sci 2020;22:E389. [PMID: 33396564 DOI: 10.3390/ijms22010389] [Cited by in Crossref: 3] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
19 Sell J, Haselmann H, Hallermann S, Hust M, Geis C. Autoimmune encephalitis: novel therapeutic targets at the preclinical level. Expert Opin Ther Targets 2021;25:37-47. [PMID: 33233983 DOI: 10.1080/14728222.2021.1856370] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 3.7] [Reference Citation Analysis]
20 Abe K, Chiba Y, Katsuse O, Takahashi Y, Suda A, Hattori S, Yoshimi R, Kirino Y, Kunii M, Yoshimi A, Asami T, Hishimoto A. Exploratory investigation on antibodies to GluN1 and cognitive dysfunction in patients with chronic autoimmune psychosis. Neurosci Lett 2021;743:135588. [PMID: 33359543 DOI: 10.1016/j.neulet.2020.135588] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
21 Choi S, Kim DH, Lee HJ, Shin DJ. Anti-LGI1 Antibody Limbic Encephalitis Associated with Hepatocellular Carcinoma. J Korean Neurol Assoc 2020;38:272-275. [DOI: 10.17340/jkna.2020.4.3] [Reference Citation Analysis]
22 Look below the Surface (EEG). Common Pitfalls in Cognitive and Behavioral Neurology 2020. [DOI: 10.1017/9781108355841.017] [Reference Citation Analysis]
23 Bechter K. The Challenge of Assessing Mild Neuroinflammation in Severe Mental Disorders. Front Psychiatry 2020;11:773. [PMID: 32973573 DOI: 10.3389/fpsyt.2020.00773] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
24 Varley JA, Irani SR. Autoantibody-mediated neurological diseases. Medicine 2020;48:534-540. [DOI: 10.1016/j.mpmed.2020.05.008] [Reference Citation Analysis]
25 Besag FM, Vasey MJ. Seizures and Epilepsy in Autism Spectrum Disorder. Child and Adolescent Psychiatric Clinics of North America 2020;29:483-500. [DOI: 10.1016/j.chc.2020.02.002] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
26 Di Giacomo R, Rossi Sebastiano D, Cazzato D, Andreetta F, Pozzi P, Cenciarelli S, Deleo F, Pastori C, Didato G, de Curtis M, Villani F. Expanding clinical spectrum of Caspr2 antibody-associated disease: warning on brainstem involvement and respiratory failure. Journal of the Neurological Sciences 2020;413:116865. [DOI: 10.1016/j.jns.2020.116865] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
27 Adib-Samii P, Little S, Vincent A, Nirmalananthan N. Case report: Headache and neurological deficits with CSF lymphocytosis (HaNDL) associated with P/Q type voltage-gated calcium channel antibodies (CACNA1A). Cephalalgia 2020;40:1003-7. [PMID: 32276550 DOI: 10.1177/0333102420916746] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
28 Buckley C, Vincent A. Autoimmune encephalitis and Morvan’s syndrome. Oxford Textbook of Medicine 2020. [DOI: 10.1093/med/9780198746690.003.0617] [Reference Citation Analysis]
29 Gastaldi M, Mariotto S, Giannoccaro MP, Iorio R, Zoccarato M, Nosadini M, Benedetti L, Casagrande S, Di Filippo M, Valeriani M, Ricci S, Bova S, Arbasino C, Mauri M, Versino M, Vigevano F, Papetti L, Romoli M, Lapucci C, Massa F, Sartori S, Zuliani L, Barilaro A, De Gaspari P, Spagni G, Evoli A, Liguori R, Ferrari S, Marchioni E, Giometto B, Massacesi L, Franciotta D. Subgroup comparison according to clinical phenotype and serostatus in autoimmune encephalitis: a multicenter retrospective study. Eur J Neurol. 2020;27:633-643. [PMID: 31814224 DOI: 10.1111/ene.14139] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 5.0] [Reference Citation Analysis]
30 Gastaldi M, Zardini E, Scaranzin S, Uccelli A, Andreetta F, Baggi F, Franciotta D. Autoantibody Diagnostics in Neuroimmunology: Experience From the 2018 Italian Neuroimmunology Association External Quality Assessment Program. Front Neurol 2019;10:1385. [PMID: 32010046 DOI: 10.3389/fneur.2019.01385] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 4.7] [Reference Citation Analysis]
31 Tang C, Tan K, Lim G, Tan L, Tay KY, Kandiah N, Abdin E, Verma SK. N-Methyl-D-Aspartate(NMDA) Receptor and Voltage-Gated Potassium Channel (VGKC) Antibody-Associated Encephalitides Presenting as First Episode Acute Psychosis. Front Psychiatry 2019;10:913. [PMID: 31920760 DOI: 10.3389/fpsyt.2019.00913] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
32 Ramanathan S, Al-Diwani A, Waters P, Irani SR. The autoantibody-mediated encephalitides: from clinical observations to molecular pathogenesis. J Neurol 2021;268:1689-707. [PMID: 31655889 DOI: 10.1007/s00415-019-09590-9] [Cited by in Crossref: 30] [Cited by in F6Publishing: 33] [Article Influence: 7.5] [Reference Citation Analysis]
33 Alexopoulos H, Dalakas MC. The immunobiology of autoimmune encephalitides. J Autoimmun. 2019;104:102339. [PMID: 31611142 DOI: 10.1016/j.jaut.2019.102339] [Cited by in Crossref: 30] [Cited by in F6Publishing: 26] [Article Influence: 7.5] [Reference Citation Analysis]
34 Stanciu GD, Bild V, Ababei DC, Rusu RN, Beschea Chiriac SI, Rezuş E, Luca A. Relevance of Surface Neuronal Protein Autoantibodies as Biomarkers in Seizure-Associated Disorders. Int J Mol Sci 2019;20:E4529. [PMID: 31540204 DOI: 10.3390/ijms20184529] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
35 Hunt MA, Nascimento DSM, Bersellini Farinotti A, Svensson CI. Autoantibodies Hurt: Transfer of Patient-Derived CASPR2 Antibodies Induces Neuropathic Pain in Mice. Neuron 2018;97:729-31. [PMID: 29470963 DOI: 10.1016/j.neuron.2018.02.008] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
36 Zhang M, Li W, Zhou S, Zhou Y, Yang H, Yu L, Wang J, Wang Y, Zhang L. Clinical Features, Treatment, and Outcomes Among Chinese Children With Anti-methyl-D-aspartate Receptor (Anti-NMDAR) Encephalitis. Front Neurol 2019;10:596. [PMID: 31244759 DOI: 10.3389/fneur.2019.00596] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 4.8] [Reference Citation Analysis]
37 Zuliani L, Nosadini M, Gastaldi M, Spatola M, Iorio R, Zoccarato M, Mariotto S, De Gaspari P, Perini F, Ferrari S, Evoli A, Sartori S, Franciotta D, Giometto B. Management of antibody-mediated autoimmune encephalitis in adults and children: literature review and consensus-based practical recommendations. Neurol Sci 2019;40:2017-30. [PMID: 31161339 DOI: 10.1007/s10072-019-03930-3] [Cited by in Crossref: 44] [Cited by in F6Publishing: 38] [Article Influence: 11.0] [Reference Citation Analysis]
38 Averna R, Battaglia C, Labonia M, Riccioni A, Vicari S. Catatonia in Adolescence: First Onset Psychosis or Anti-NMDAr Encephalitis? Clin Neuropharm 2019;42:136-8. [DOI: 10.1097/wnf.0000000000000348] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
39 Thompson J, Bi M, Murchison AG, Makuch M, Bien CG, Chu K, Farooque P, Gelfand JM, Geschwind MD, Hirsch LJ, Somerville E, Lang B, Vincent A, Leite MI, Waters P, Irani SR; Faciobrachial Dystonic Seizures Study Group. The importance of early immunotherapy in patients with faciobrachial dystonic seizures. Brain 2018;141:348-56. [PMID: 29272336 DOI: 10.1093/brain/awx323] [Cited by in Crossref: 199] [Cited by in F6Publishing: 204] [Article Influence: 49.8] [Reference Citation Analysis]
40 Balint B, Vincent A, Meinck HM, Irani SR, Bhatia KP. Movement disorders with neuronal antibodies: syndromic approach, genetic parallels and pathophysiology. Brain 2018;141:13-36. [PMID: 29053777 DOI: 10.1093/brain/awx189] [Cited by in Crossref: 109] [Cited by in F6Publishing: 111] [Article Influence: 27.3] [Reference Citation Analysis]
41 Younger DS. Autoimmune Encephalitides. Neurol Clin 2019;37:359-81. [PMID: 30952414 DOI: 10.1016/j.ncl.2019.01.015] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
42 Moritz CP, Tholance Y, Rosier C, Reynaud-Federspiel E, Svahn J, Camdessanché JP, Antoine JC. Completing the Immunological Fingerprint by Refractory Proteins: Autoantibody Screening via an Improved Immunoblotting Technique. Proteomics Clin Appl 2019;13:e1800157. [PMID: 30768763 DOI: 10.1002/prca.201800157] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
43 Venkatesan A, Michael BD, Probasco JC, Geocadin RG, Solomon T. Acute encephalitis in immunocompetent adults. Lancet 2019;393:702-16. [PMID: 30782344 DOI: 10.1016/S0140-6736(18)32526-1] [Cited by in Crossref: 60] [Cited by in F6Publishing: 59] [Article Influence: 15.0] [Reference Citation Analysis]
44 Al-Diwani A, Handel A, Townsend L, Pollak T, Leite MI, Harrison PJ, Lennox BR, Okai D, Manohar SG, Irani SR. The psychopathology of NMDAR-antibody encephalitis in adults: a systematic review and phenotypic analysis of individual patient data. Lancet Psychiatry 2019;6:235-46. [PMID: 30765329 DOI: 10.1016/S2215-0366(19)30001-X] [Cited by in Crossref: 110] [Cited by in F6Publishing: 114] [Article Influence: 27.5] [Reference Citation Analysis]
45 Casciato S, Morano A, Fattouch J, Fanella M, Avorio F, Albini M, Basili LM, Cerulli Irelli E, Viganò A, De Risi M, Grammaldo LG, D'Aniello A, Mascia A, Manfredi M, Quarato P, Giallonardo AT, Di Gennaro G, Di Bonaventura C. Factors underlying the development of chronic temporal lobe epilepsy in autoimmune encephalitis. J Neurol Sci 2019;396:102-7. [PMID: 30447604 DOI: 10.1016/j.jns.2018.10.026] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 2.8] [Reference Citation Analysis]
46 Franciotta D, Uccelli A; Under the auspices of the Italian Association of Neuroimmunology (AINI). A bridge between evidence-based laboratory diagnostics and research in neuroimmunology: why standardizations and guidelines matter. Neurol Sci 2017;38:213-6. [PMID: 29030771 DOI: 10.1007/s10072-017-3022-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
47 Damato V, Balint B, Kienzler AK, Irani SR. The clinical features, underlying immunology, and treatment of autoantibody-mediated movement disorders. Mov Disord 2018;33:1376-89. [PMID: 30218501 DOI: 10.1002/mds.27446] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 6.2] [Reference Citation Analysis]
48 Kinsella JA, Irani SR, Hollingsworth R, O'Shaughnessy D, Kane P, Foster M, Schott JM, Lunn MP. Use of intravenous immunoglobulin for the treatment of autoimmune encephalitis: audit of the NHS experience. JRSM Open 2018;9:2054270418793021. [PMID: 30202534 DOI: 10.1177/2054270418793021] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
49 Bing-Lei W, Jia-Hua Z, Yan L, Zan Y, Xin B, Jian-Hua S, Hui-Juan W. Three cases of antibody-LGI1 limbic encephalitis and review of literature. Int J Neurosci 2019;129:642-8. [PMID: 30112956 DOI: 10.1080/00207454.2018.1512985] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
50 Li W, Wu S, Meng Q, Zhang X, Guo Y, Cong L, Cong S, Zheng D. Clinical characteristics and short-term prognosis of LGI1 antibody encephalitis: a retrospective case study. BMC Neurol 2018;18:96. [PMID: 29980179 DOI: 10.1186/s12883-018-1099-z] [Cited by in Crossref: 29] [Cited by in F6Publishing: 31] [Article Influence: 5.8] [Reference Citation Analysis]
51 Giil LM, Aarsland D, Hellton K, Lund A, Heidecke H, Schulze-forster K, Riemekasten G, Vik-mo AO, Kristoffersen EK, Vedeler CA, Nordrehaug JE. Antibodies to Multiple Receptors are Associated with Neuropsychiatric Symptoms and Mortality in Alzheimer’s Disease: A Longitudinal Study. JAD 2018;64:761-74. [DOI: 10.3233/jad-170882] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
52 Ambrose PA, Maddison P. Lambert-Eaton myasthenic syndrome and cerebellar ataxia: is Response to immunotherapy a clue to pathogenesis? Muscle Nerve 2018;58:4-6. [DOI: 10.1002/mus.26079] [Reference Citation Analysis]
53 Akhtar RS, Licata JP, Luk KC, Shaw LM, Trojanowski JQ, Lee VM. Measurements of auto-antibodies to α-synuclein in the serum and cerebral spinal fluids of patients with Parkinson's disease. J Neurochem 2018;145:489-503. [PMID: 29500813 DOI: 10.1111/jnc.14330] [Cited by in Crossref: 32] [Cited by in F6Publishing: 34] [Article Influence: 6.4] [Reference Citation Analysis]
54 Varley J, Taylor J, Irani SR. Autoantibody-mediated diseases of the CNS: Structure, dysfunction and therapy. Neuropharmacology 2018;132:71-82. [DOI: 10.1016/j.neuropharm.2017.04.046] [Cited by in Crossref: 38] [Cited by in F6Publishing: 40] [Article Influence: 7.6] [Reference Citation Analysis]
55 Xia J, Yin X, Zhu M, Cao J, Song X. Autoimmune encephalitis positive for both anti-γ-aminobutyric acid B receptor and anticollapsin response-mediator protein 5 antibodies: A case report. Medicine (Baltimore) 2018;97:e9574. [PMID: 29504979 DOI: 10.1097/MD.0000000000009574] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
56 Zarkali A, Cousins O, Athauda D, Moses S, Moran N, Harikrishnan S. Glial fibrillary acidic protein antibody-positive meningoencephalomyelitis. Pract Neurol 2018;18:315-9. [PMID: 29440316 DOI: 10.1136/practneurol-2017-001863] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
57 Yaguchi H, Yabe I, Takahashi H, Watanabe M, Nomura T, Kano T, Watanabe M, Hatakeyama S. Anti-Sez6l2 antibody detected in a patient with immune-mediated cerebellar ataxia inhibits complex formation of GluR1 and Sez6l2. J Neurol 2018;265:962-5. [PMID: 29423613 DOI: 10.1007/s00415-018-8785-z] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
58 Newman M, Airey C, Blum S, Scott JG, Wong RC, Gillis D. Autoimmune Encephalitis. Neuroinflammation 2018. [DOI: 10.1016/b978-0-12-811709-5.00010-7] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
59 Ramanathan S, Irani SR. Autoantibody-Mediated Forms of Encephalitis. Reference Module in Neuroscience and Biobehavioral Psychology 2018. [DOI: 10.1016/b978-0-12-809324-5.23545-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
60 Garcia-Tarodo S, Datta AN, Ramelli GP, Maréchal-Rouiller F, Bien CG, Korff CM. Circulating neural antibodies in unselected children with new-onset seizures. Eur J Paediatr Neurol 2018;22:396-403. [PMID: 29291919 DOI: 10.1016/j.ejpn.2017.12.007] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
61 Kunze A, Reuber M. The first seizure as an indicator of epilepsy. Curr Opin Neurol 2018;31:156-61. [PMID: 29256931 DOI: 10.1097/WCO.0000000000000529] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
62 Besag FM. Epilepsy in patients with autism: links, risks and treatment challenges. Neuropsychiatr Dis Treat. 2018;14:1-10. [PMID: 29296085 DOI: 10.2147/ndt.s120509] [Cited by in Crossref: 71] [Cited by in F6Publishing: 77] [Article Influence: 11.8] [Reference Citation Analysis]
63 Binks SNM, Klein CJ, Waters P, Pittock SJ, Irani SR. LGI1, CASPR2 and related antibodies: a molecular evolution of the phenotypes. J Neurol Neurosurg Psychiatry 2018;89:526-34. [PMID: 29055902 DOI: 10.1136/jnnp-2017-315720] [Cited by in Crossref: 103] [Cited by in F6Publishing: 102] [Article Influence: 17.2] [Reference Citation Analysis]
64 Zuliani L, Zoccarato M, Gastaldi M, Iorio R, Evoli A, Biagioli T, Casagrande S, Bazzigaluppi E, Fazio R, Giannotta C, Nobile-orazio E, Andreetta F, Simoncini O, Costa G, Mariotto S, Ferrari S, Galloni E, Marcon M, Franciotta D, Giometto B. Diagnostics of autoimmune encephalitis associated with antibodies against neuronal surface antigens. Neurol Sci 2017;38:225-9. [DOI: 10.1007/s10072-017-3032-4] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 2.5] [Reference Citation Analysis]
65 Yaguchi H, Yabe I, Takahashi H, Watanabe M, Nomura T, Kano T, Matsumoto M, Nakayama KI, Watanabe M, Hatakeyama S. Sez6l2 regulates phosphorylation of ADD and neuritogenesis. Biochem Biophys Res Commun 2017;494:234-41. [PMID: 29032200 DOI: 10.1016/j.bbrc.2017.10.047] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 2.7] [Reference Citation Analysis]
66 Abboud H, Rossman I, Mealy MA, Hill E, Thompson N, Banerjee A, Probasco J, Levy M. Neuronal autoantibodies: differentiating clinically relevant and clinically irrelevant results. J Neurol 2017;264:2284-92. [DOI: 10.1007/s00415-017-8627-4] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 2.7] [Reference Citation Analysis]
67 Iorio R, Damato V, Evoli A, Gessi M, Gaudino S, Di Lazzaro V, Spagni G, Sluijs JA, Hol EM. Clinical and immunological characteristics of the spectrum of GFAP autoimmunity: a case series of 22 patients. J Neurol Neurosurg Psychiatry 2018;89:138-46. [DOI: 10.1136/jnnp-2017-316583] [Cited by in Crossref: 86] [Cited by in F6Publishing: 89] [Article Influence: 14.3] [Reference Citation Analysis]
68 Lee WJ, Lee ST, Moon J, Sunwoo JS, Byun JI, Lim JA, Kim TJ, Shin YW, Lee KJ, Jun JS, Lee HS, Kim S, Park KI, Jung KH, Jung KY, Kim M, Lee SK, Chu K. Tocilizumab in Autoimmune Encephalitis Refractory to Rituximab: An Institutional Cohort Study. Neurotherapeutics 2016;13:824-32. [PMID: 27215218 DOI: 10.1007/s13311-016-0442-6] [Cited by in Crossref: 146] [Cited by in F6Publishing: 146] [Article Influence: 24.3] [Reference Citation Analysis]
69 Sculier C, Bentea G, Ruelle L, Grigoriu B, Coureau M, Gorham J, Sideris S, Holbrechts S, Lafitte J, Meert A, Durieux V, Berghmans T, Sculier J. Autoimmune paraneoplastic syndromes associated to lung cancer: A systematic review of the literature: Part 5: Neurological auto-antibodies, discussion, flow chart, conclusions. Lung Cancer 2017;111:164-75. [DOI: 10.1016/j.lungcan.2017.07.026] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
70 Finke C, Bartels F, Lütt A, Prüss H, Harms L. High prevalence of neuronal surface autoantibodies associated with cognitive deficits in cancer patients. J Neurol 2017;264:1968-77. [PMID: 28785798 DOI: 10.1007/s00415-017-8582-0] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 2.5] [Reference Citation Analysis]
71 Zong S, Hoffmann C, Mané-Damas M, Molenaar P, Losen M, Martinez-Martinez P. Neuronal Surface Autoantibodies in Neuropsychiatric Disorders: Are There Implications for Depression? Front Immunol 2017;8:752. [PMID: 28725222 DOI: 10.3389/fimmu.2017.00752] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
72 Gris J, Cyprien F, Bouvier S, Cochery-nouvellon E, Lavigne-lissalde G, Mercier E, Balducchi J. Antiphospholipid antibodies are associated with positive screening for common mental disorders in women with previous pregnancy loss. The NOHA-PSY observational study. The World Journal of Biological Psychiatry 2019;20:51-63. [DOI: 10.1080/15622975.2017.1333146] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
73 Pilli D, Zou A, Tea F, Dale RC, Brilot F. Expanding Role of T Cells in Human Autoimmune Diseases of the Central Nervous System. Front Immunol 2017;8:652. [PMID: 28638382 DOI: 10.3389/fimmu.2017.00652] [Cited by in Crossref: 49] [Cited by in F6Publishing: 51] [Article Influence: 8.2] [Reference Citation Analysis]
74 Pollak TA, Moran N. Emergence of new-onset psychotic disorder following recovery from LGI1 antibody-associated limbic encephalitis. BMJ Case Rep 2017;2017:bcr2016218328. [PMID: 28363946 DOI: 10.1136/bcr-2016-218328] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
75 Sauer M, Heilemann M. Single-Molecule Localization Microscopy in Eukaryotes. Chem Rev 2017;117:7478-509. [PMID: 28287710 DOI: 10.1021/acs.chemrev.6b00667] [Cited by in Crossref: 257] [Cited by in F6Publishing: 256] [Article Influence: 42.8] [Reference Citation Analysis]
76 Zhang L, Wu M, Hao Z, Chiang SMV, Shuang K, Lin M, Chi X, Fang J, Zhou D, Li J. Clinical characteristics, treatments, and outcomes of patients with anti- N -methyl- d -aspartate receptor encephalitis: A systematic review of reported cases. Epilepsy & Behavior 2017;68:57-65. [DOI: 10.1016/j.yebeh.2016.12.019] [Cited by in Crossref: 43] [Cited by in F6Publishing: 49] [Article Influence: 7.2] [Reference Citation Analysis]
77 Waters PJ, Irani SR. G 2 A 1 B 3 A A receptor antibodies and their clinical associations. Neurology 2017;88:1010-1. [DOI: 10.1212/wnl.0000000000003758] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
78 Flanagan EP, Drubach DA, Boeve BF. Autoimmune dementia and encephalopathy. Handb Clin Neurol 2016;133:247-67. [PMID: 27112681 DOI: 10.1016/B978-0-444-63432-0.00014-1] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
79 Irani SR, Vincent A. Voltage-gated potassium channel-complex autoimmunity and associated clinical syndromes. Handb Clin Neurol 2016;133:185-97. [PMID: 27112678 DOI: 10.1016/B978-0-444-63432-0.00011-6] [Cited by in Crossref: 40] [Cited by in F6Publishing: 28] [Article Influence: 6.7] [Reference Citation Analysis]
80 Al-Diwani A, Pollak TA, Langford AE, Lennox BR. Synaptic and Neuronal Autoantibody-Associated Psychiatric Syndromes: Controversies and Hypotheses. Front Psychiatry 2017;8:13. [PMID: 28220082 DOI: 10.3389/fpsyt.2017.00013] [Cited by in Crossref: 38] [Cited by in F6Publishing: 41] [Article Influence: 6.3] [Reference Citation Analysis]
81 Sayeh A, Ben Cheikh C, Mardessi A, Mrad M, Nsiri B, Oumaya A, Fekih-Mrissa N. HLA DRB1*03 as a possible common etiology of schizophrenia, Graves' disease, and type 2 diabetes. Ann Gen Psychiatry 2017;16:7. [PMID: 28174595 DOI: 10.1186/s12991-017-0128-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
82 Lang B, Makuch M, Moloney T, Dettmann I, Mindorf S, Probst C, Stoecker W, Buckley C, Newton CR, Leite MI, Maddison P, Komorowski L, Adcock J, Vincent A, Waters P, Irani SR. Intracellular and non-neuronal targets of voltage-gated potassium channel complex antibodies. J Neurol Neurosurg Psychiatry 2017;88:353-61. [PMID: 28115470 DOI: 10.1136/jnnp-2016-314758] [Cited by in Crossref: 97] [Cited by in F6Publishing: 99] [Article Influence: 16.2] [Reference Citation Analysis]
83 Younger DS. Autoimmune Encephalitides. WJNS 2017;07:327-361. [DOI: 10.4236/wjns.2017.73027] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
84 Dale RC. Immune-Mediated Epilepsy, Movement Disorders, and Hashimoto’s Encephalopathy in Children. Swaiman's Pediatric Neurology 2017. [DOI: 10.1016/b978-0-323-37101-8.00119-3] [Reference Citation Analysis]
85 Rüegg S, Irani SR. The trouble with plasma cells: Getting to the root cause. Neurology 2017;88:340-1. [PMID: 28003504 DOI: 10.1212/WNL.0000000000003545] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
86 Litmeier S, Prüss H, Witsch E, Witsch J. Initial serum thyroid peroxidase antibodies and long-term outcomes in SREAT. Acta Neurol Scand 2016;134:452-7. [PMID: 26757046 DOI: 10.1111/ane.12556] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 3.1] [Reference Citation Analysis]
87 Bost C, Pascual O, Honnorat J. Autoimmune encephalitis in psychiatric institutions: current perspectives. Neuropsychiatr Dis Treat 2016;12:2775-87. [PMID: 27822050 DOI: 10.2147/NDT.S82380] [Cited by in Crossref: 40] [Cited by in F6Publishing: 40] [Article Influence: 5.7] [Reference Citation Analysis]
88 Zandi MS. Autoimmune Encephalitis. Focus (Am Psychiatr Publ) 2016;14:432-6. [PMID: 31975823 DOI: 10.1176/appi.focus.20160019] [Reference Citation Analysis]
89 Varley JA, Irani SR. Antibody-associated autoimmune neurological disease. Medicine 2016;44:563-569. [DOI: 10.1016/j.mpmed.2016.06.008] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
90 Sinmaz N, Nguyen T, Tea F, Dale RC, Brilot F. Mapping autoantigen epitopes: molecular insights into autoantibody-associated disorders of the nervous system. J Neuroinflammation 2016;13:219. [PMID: 27577085 DOI: 10.1186/s12974-016-0678-4] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 4.3] [Reference Citation Analysis]
91 Lang K, Prüß H. Anti-NMDA-Rezeptor-Enzephalitis — eine wichtige Differenzialdiagnose. InFo Neurologie 2016;18:40-48. [DOI: 10.1007/s15005-016-1780-y] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
92 Bakpa OD, Reuber M, Irani SR. Antibody-associated epilepsies: Clinical features, evidence for immunotherapies and future research questions. Seizure 2016;41:26-41. [PMID: 27450643 DOI: 10.1016/j.seizure.2016.07.002] [Cited by in Crossref: 32] [Cited by in F6Publishing: 33] [Article Influence: 4.6] [Reference Citation Analysis]
93 Irani SR. 'Moonlighting' surface antigens: a paradigm for autoantibody pathogenicity in neurology? Brain 2016;139:304-6. [PMID: 26912515 DOI: 10.1093/brain/awv364] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 2.9] [Reference Citation Analysis]
94 Spinello C, Laviola G, Macrì S. Pediatric Autoimmune Disorders Associated with Streptococcal Infections and Tourette's Syndrome in Preclinical Studies. Front Neurosci 2016;10:310. [PMID: 27445678 DOI: 10.3389/fnins.2016.00310] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 1.7] [Reference Citation Analysis]
95 Dinkins MB, Dasgupta S, Wang G, Zhu G, He Q, Kong JN, Bieberich E. The 5XFAD Mouse Model of Alzheimer's Disease Exhibits an Age-Dependent Increase in Anti-Ceramide IgG and Exogenous Administration of Ceramide Further Increases Anti-Ceramide Titers and Amyloid Plaque Burden. J Alzheimers Dis 2015;46:55-61. [PMID: 25720409 DOI: 10.3233/JAD-150088] [Cited by in Crossref: 50] [Cited by in F6Publishing: 55] [Article Influence: 7.1] [Reference Citation Analysis]
96 Grisold W, Grisold A, Löscher WN. Neuromuscular complications in cancer. J Neurol Sci 2016;367:184-202. [PMID: 27423586 DOI: 10.1016/j.jns.2016.06.002] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.9] [Reference Citation Analysis]
97 Dawes JM, Vincent A. Autoantibodies and pain. Current Opinion in Supportive & Palliative Care 2016;10:137-42. [DOI: 10.1097/spc.0000000000000211] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
98 Dubey D, Blackburn K, Greenberg B, Stuve O, Vernino S. Diagnostic and therapeutic strategies for management of autoimmune encephalopathies. Expert Rev Neurother 2016;16:937-49. [PMID: 27171736 DOI: 10.1080/14737175.2016.1189328] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 2.6] [Reference Citation Analysis]
99 Vollmer TL, Mccarthy M. Autoimmune encephalitis: A more treatable tragedy if diagnosed early. Neurology 2016;86:1655-6. [DOI: 10.1212/wnl.0000000000002641] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 2.1] [Reference Citation Analysis]
100 Wright S, Geerts AT, Jol-van der Zijde CM, Jacobson L, Lang B, Waters P, van Tol MJ, Stroink H, Neuteboom RF, Brouwer OF, Vincent A. Neuronal antibodies in pediatric epilepsy: Clinical features and long-term outcomes of a historical cohort not treated with immunotherapy. Epilepsia 2016;57:823-31. [PMID: 26996997 DOI: 10.1111/epi.13356] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 4.4] [Reference Citation Analysis]
101 Hacohen Y, Nishimoto Y, Fukami Y, Lang B, Waters P, Lim MJ, Yuki N, Vincent A. Paediatric brainstem encephalitis associated with glial and neuronal autoantibodies. Dev Med Child Neurol 2016;58:836-41. [DOI: 10.1111/dmcn.13090] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 3.4] [Reference Citation Analysis]
102 Byun JI, Lee ST, Jung KH, Sunwoo JS, Moon J, Kim TJ, Lim JA, Kim S, Kim DY, Han SH, Jang H, Suh HI, Cho AH, Kim DW, Shin JW, Koo YS, Choi WC, Lee WW, Choi N, Kim S, Nam H, Koo DL, Kim M, Lim BC, Chae JH, Kim KJ, Jeon D, Park KI, Jung KY, Kim M, Chu K, Lee SK. Prevalence of antineuronal antibodies in patients with encephalopathy of unknown etiology: Data from a nationwide registry in Korea. J Neuroimmunol 2016;293:34-8. [PMID: 27049559 DOI: 10.1016/j.jneuroim.2016.02.002] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.7] [Reference Citation Analysis]
103 Bamford A, Lim M. Autoimmune encephalitis following haematopoietic stem cell transplant: a new clinical entity or a previously unrecognised one? Transl Pediatr 2015;4:327-30. [PMID: 26835396 DOI: 10.3978/j.issn.2224-4336.2015.10.04] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
104 Morrow J. Autoimmune limbic encephalitis due to VGKC-Ab. Thanks for the memory . Leo Robin (Title of song, 1937). Pract Neurol 2016;16:162-5. [DOI: 10.1136/practneurol-2015-001313] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
105 Michael BD, Griffiths MJ, Granerod J, Brown D, Davies NW, Borrow R, Solomon T. Characteristic Cytokine and Chemokine Profiles in Encephalitis of Infectious, Immune-Mediated, and Unknown Aetiology. PLoS One 2016;11:e0146288. [PMID: 26808276 DOI: 10.1371/journal.pone.0146288] [Cited by in Crossref: 30] [Cited by in F6Publishing: 31] [Article Influence: 4.3] [Reference Citation Analysis]
106 Lim M, Gorman M. Autoimmune neurologic disorders in children. Handb Clin Neurol 2016;133:485-510. [PMID: 27112693 DOI: 10.1016/B978-0-444-63432-0.00026-8] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
107 Wekerle H, Hohlfeld R. Gut Microbiota in Multiple Sclerosis. Translational Neuroimmunology in Multiple Sclerosis 2016. [DOI: 10.1016/b978-0-12-801914-6.00009-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
108 Bradl M, Lassmann H. Neurologic autoimmunity: mechanisms revealed by animal models. Handb Clin Neurol 2016;133:121-43. [PMID: 27112675 DOI: 10.1016/B978-0-444-63432-0.00008-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
109 Pollak TA, Beck K, Irani SR, Howes OD, David AS, McGuire PK. Autoantibodies to central nervous system neuronal surface antigens: psychiatric symptoms and psychopharmacological implications. Psychopharmacology (Berl) 2016;233:1605-21. [PMID: 26667479 DOI: 10.1007/s00213-015-4156-y] [Cited by in Crossref: 45] [Cited by in F6Publishing: 48] [Article Influence: 5.6] [Reference Citation Analysis]
110 Sunwoo JS, Chu K, Byun JI, Moon J, Lim JA, Kim TJ, Lee ST, Jung KH, Park KI, Jeon D, Jung KY, Kim M, Lee SK. Intrathecal-specific glutamic acid decarboxylase antibodies at low titers in autoimmune neurological disorders. J Neuroimmunol 2016;290:15-21. [PMID: 26711563 DOI: 10.1016/j.jneuroim.2015.11.012] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
111 Nosadini M, Mohammad SS, Ramanathan S, Brilot F, Dale RC. Immune therapy in autoimmune encephalitis: a systematic review. Expert Review of Neurotherapeutics 2015;15:1391-419. [DOI: 10.1586/14737175.2015.1115720] [Cited by in Crossref: 121] [Cited by in F6Publishing: 125] [Article Influence: 15.1] [Reference Citation Analysis]
112 Werner C, Pauli M, Doose S, Weishaupt A, Haselmann H, Grünewald B, Sauer M, Heckmann M, Toyka KV, Asan E, Sommer C, Geis C. Human autoantibodies to amphiphysin induce defective presynaptic vesicle dynamics and composition. Brain 2016;139:365-79. [DOI: 10.1093/brain/awv324] [Cited by in Crossref: 44] [Cited by in F6Publishing: 45] [Article Influence: 5.5] [Reference Citation Analysis]
113 Heine J, Prüss H, Bartsch T, Ploner C, Paul F, Finke C. Imaging of autoimmune encephalitis – Relevance for clinical practice and hippocampal function. Neuroscience 2015;309:68-83. [DOI: 10.1016/j.neuroscience.2015.05.037] [Cited by in Crossref: 157] [Cited by in F6Publishing: 165] [Article Influence: 19.6] [Reference Citation Analysis]
114 Venkatesan A, Benavides DR. Autoimmune encephalitis and its relation to infection. Curr Neurol Neurosci Rep 2015;15:3. [PMID: 25637289 DOI: 10.1007/s11910-015-0529-1] [Cited by in Crossref: 53] [Cited by in F6Publishing: 57] [Article Influence: 6.6] [Reference Citation Analysis]
115 Bartsch T, Wulff P. The hippocampus in aging and disease: From plasticity to vulnerability. Neuroscience 2015;309:1-16. [PMID: 26241337 DOI: 10.1016/j.neuroscience.2015.07.084] [Cited by in Crossref: 204] [Cited by in F6Publishing: 211] [Article Influence: 25.5] [Reference Citation Analysis]
116 Le Dault E, Lagarde S, Guedj E, Dufournet B, Rey C, Kaphan E, Tanguy G, Bregigeon M, Sagui E, Brosset C. [Unexplicated neuropsychiatric disorders: Do not ignore dysimmune encephalitis. A case report of a dysimmune encephalitis with anti-leucine rich glioma inactivated 1 (LGI-1) antibodies]. Rev Med Interne 2016;37:127-30. [PMID: 26164401 DOI: 10.1016/j.revmed.2015.06.007] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
117 Gozzard P, Woodhall M, Chapman C, Nibber A, Waters P, Vincent A, Lang B, Maddison P. Paraneoplastic neurologic disorders in small cell lung carcinoma: A prospective study. Neurology 2015;85:235-9. [PMID: 26109714 DOI: 10.1212/WNL.0000000000001721] [Cited by in Crossref: 69] [Cited by in F6Publishing: 77] [Article Influence: 8.6] [Reference Citation Analysis]
118 Sinmaz N, Amatoury M, Merheb V, Ramanathan S, Dale RC, Brilot F. Autoantibodies in movement and psychiatric disorders: updated concepts in detection methods, pathogenicity, and CNS entry: Autoantibody-associated brain disorders. Ann N Y Acad Sci 2015;1351:22-38. [DOI: 10.1111/nyas.12764] [Cited by in Crossref: 38] [Cited by in F6Publishing: 39] [Article Influence: 4.8] [Reference Citation Analysis]
119 Moloney TC, Idris I, Waters P, Howell S, Vincent A, Lang B, Maddison P. Autoantibodies to glutamic acid decarboxylase in patients with epilepsy and their relationship with type 1 diabetes: a pilot study: Table 1. J Neurol Neurosurg Psychiatry 2016;87:676-7. [DOI: 10.1136/jnnp-2015-310512] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
120 Lagarde S, Guedj E. Apport de la tomographie par émission de positons (TEP) cérébrale dans les encéphalites dysimmunitaires. Médecine Nucléaire 2015;39:279-282. [DOI: 10.1016/j.mednuc.2015.03.002] [Reference Citation Analysis]
121 Wang R, Guan HZ, Ren HT, Wang W, Hong Z, Zhou D. CSF findings in patients with anti-N-methyl-D-aspartate receptor-encephalitis. Seizure 2015;29:137-42. [PMID: 26076857 DOI: 10.1016/j.seizure.2015.04.005] [Cited by in Crossref: 60] [Cited by in F6Publishing: 62] [Article Influence: 7.5] [Reference Citation Analysis]
122 Lim M, Hacohen Y, Vincent A. Autoimmune encephalopathies. Pediatr Clin North Am 2015;62:667-85. [PMID: 26022169 DOI: 10.1016/j.pcl.2015.03.011] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 2.9] [Reference Citation Analysis]
123 Bale JF Jr. Virus and Immune-Mediated Encephalitides: Epidemiology, Diagnosis, Treatment, and Prevention. Pediatr Neurol 2015;53:3-12. [PMID: 25957806 DOI: 10.1016/j.pediatrneurol.2015.03.013] [Cited by in Crossref: 58] [Cited by in F6Publishing: 47] [Article Influence: 7.3] [Reference Citation Analysis]
124 Rodriguez Cruz PM, Huda S, López-Ruiz P, Vincent A. Use of cell-based assays in myasthenia gravis and other antibody-mediated diseases. Exp Neurol 2015;270:66-71. [PMID: 25783660 DOI: 10.1016/j.expneurol.2015.01.011] [Cited by in Crossref: 39] [Cited by in F6Publishing: 42] [Article Influence: 4.9] [Reference Citation Analysis]
125 Sunwoo JS, Lee ST, Byun JI, Moon J, Shin JW, Jeong DE, Lee GH, Jeong SH, Shin YW, Jung KH, Lee DY, Jeon D, Jung KY, Kim M, Lee SK, Chu K. Clinical manifestations of patients with CASPR2 antibodies. J Neuroimmunol 2015;281:17-22. [PMID: 25867463 DOI: 10.1016/j.jneuroim.2015.03.005] [Cited by in Crossref: 38] [Cited by in F6Publishing: 42] [Article Influence: 4.8] [Reference Citation Analysis]
126 Shen Y, Ge WP, Li Y, Hirano A, Lee HY, Rohlmann A, Missler M, Tsien RW, Jan LY, Fu YH, Ptáček LJ. Protein mutated in paroxysmal dyskinesia interacts with the active zone protein RIM and suppresses synaptic vesicle exocytosis. Proc Natl Acad Sci U S A 2015;112:2935-41. [PMID: 25730884 DOI: 10.1073/pnas.1501364112] [Cited by in Crossref: 37] [Cited by in F6Publishing: 37] [Article Influence: 4.6] [Reference Citation Analysis]
127 Rao VR, Lim LE, Fong D, Garga NI, Parko KL. Multicentric Castleman's disease with voltage-gated potassium channel antibody-positive limbic encephalitis: a case report. BMC Neurol 2015;15:4. [PMID: 25648431 DOI: 10.1186/s12883-015-0266-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
128 Stathopoulos P, Alexopoulos H, Dalakas MC. Autoimmune antigenic targets at the node of Ranvier in demyelinating disorders. Nat Rev Neurol 2015;11:143-56. [DOI: 10.1038/nrneurol.2014.260] [Cited by in Crossref: 77] [Cited by in F6Publishing: 81] [Article Influence: 9.6] [Reference Citation Analysis]
129 Paul NLM, Kleinig TJ. Therapy of paraneoplastic disorders of the CNS. Expert Review of Neurotherapeutics 2015;15:187-93. [DOI: 10.1586/14737175.2015.1000310] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
130 Varley J, Vincent A, Irani SR. Clinical and experimental studies of potentially pathogenic brain-directed autoantibodies: current knowledge and future directions. J Neurol. 2015;262:1081-1095. [PMID: 25491076 DOI: 10.1007/s00415-014-7600-8] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 2.3] [Reference Citation Analysis]
131 Suleiman J, Dale RC. The recognition and treatment of autoimmune epilepsy in children. Dev Med Child Neurol 2015;57:431-40. [PMID: 25483277 DOI: 10.1111/dmcn.12647] [Cited by in Crossref: 35] [Cited by in F6Publishing: 60] [Article Influence: 3.9] [Reference Citation Analysis]
132 Willcox N. The Immunogenetics of the Autoimmune Myasthenias. eLS 2014. [DOI: 10.1002/9780470015902.a0024896] [Reference Citation Analysis]